Human Molecular Genetics, 2002, Vol. 11, No. 4 389-396
© 2002 Oxford University Press
KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis
Department of Genetics, Duke University Medical Center, Durham, NC 27710, USA, 1Division of Basic Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA and 2Department of Pediatrics, New York University Medical Center, New York, NY 10016, USA
Mutations in KRIT1, a protein initially identified based on a yeast two-hybrid interaction with the RAS-family GTPase RAP1A, are responsible for the development of the inherited vascular disorder cerebral cavernous malformations (CCM1). As the function of the KRIT1 protein and its role in CCM pathogenesis remain unknown, we performed yeast two-hybrid screens to identify additional protein binding partners. A fragment containing the N-terminal 272 amino acid residues of KRIT1, a region lacking similarity to any known protein upon database searches, was used as bait. From parallel screens of human fetal brain and HeLa cDNA libraries, we obtained multiple independent isolates of human integrin cytoplasmic domain-associated protein-1 (ICAP-1) as interacting clones. The interaction of KRIT1 and ICAP-1 was confirmed by GST-KRIT1 trapping of endogenous ICAP-1 from 293T cells. The
isoform of ICAP-1 is a 200 amino acid serine/threonine-rich phosphoprotein which binds the cytoplasmic tail of ß1 integrins. We show that mutagenesis of the N-terminal KRIT1 NPXY amino acid sequence, a motif critical for ICAP-1 binding to ß1 integrin molecules, completely abrogates the KRIT1/ICAP-1 interaction. The interaction between ICAP-1 and KRIT1, and the presence of a FERM domain in the latter, suggest that KRIT1 might be involved in the bidirectional signaling between integrin molecules and the cytoskeleton. Furthermore, these data suggest that KRIT1 might affect cell adhesion processes via integrin signaling in CCM1 pathogenesis.
+ To whom correspondence should be addressed. Tel: +1 919 684 3290; Fax: +1 919 681 9193; Email: march004@mc.duke.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Chen, G. Tanriover, H. Yano, R. Friedlander, A. Louvi, and M. Gunel Apoptotic Functions of PDCD10/CCM3, the Gene Mutated in Cerebral Cavernous Malformation 3 Stroke, April 1, 2009; 40(4): 1474 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Akers, E. Johnson, G. K. Steinberg, J. M. Zabramski, and D. A. Marchuk Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis Hum. Mol. Genet., March 1, 2009; 18(5): 919 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boulday, A. Blecon, N. Petit, F. Chareyre, L. A. Garcia, M. Niwa-Kawakita, M. Giovannini, and E. Tournier-Lasserve Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations Dis. Model. Mech., March 1, 2009; 2(3-4): 168 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Hogan, J. Bussmann, H. Wolburg, and S. Schulte-Merker ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish Hum. Mol. Genet., August 15, 2008; 17(16): 2424 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lei, D. Liu, Y. Huang, I. Jovin, S.-Y. Shai, T. Kyriakides, R. S. Ross, and F. J. Giordano Endothelial Expression of 1 Integrin Is Required for Embryonic Vascular Patterning and Postnatal Vascular Remodeling Mol. Cell. Biol., January 15, 2008; 28(2): 794 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Glading, J. Han, R. A. Stockton, and M. H. Ginsberg KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions J. Cell Biol., October 22, 2007; 179(2): 247 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brouillard and M. Vikkula Genetic causes of vascular malformations Hum. Mol. Genet., October 15, 2007; 16(R2): R140 - R149. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bouvard, A. Aszodi, G. Kostka, M. R. Block, C. Albiges-Rizo, and R. Fassler Defective osteoblast function in ICAP-1-deficient mice Development, July 15, 2007; 134(14): 2615 - 2625. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rossi, R. Manfredini, F. Bertolini, D. Ferrari, M. Fogli, R. Zini, S. Salati, V. Salvestrini, S. Gulinelli, E. Adinolfi, et al. The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration Blood, January 15, 2007; 109(2): 533 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Revencu and M Vikkula Cerebral cavernous malformation: new molecular and clinical insights J. Med. Genet., September 1, 2006; 43(9): 716 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Mably, L. P. Chuang, F. C. Serluca, M.-A. P. K. Mohideen, J.-N. Chen, and M. C. Fishman santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish Development, August 15, 2006; 133(16): 3139 - 3146. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishimaru, H. Inada, M. Kubota, H. Zhuang, M. Tominaga, and H. Matsunami Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor PNAS, August 15, 2006; 103(33): 12569 - 12574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seker, K. L. Pricola, B. Guclu, A. K. Ozturk, A. Louvi, and M. Gunel CCM2 Expression Parallels That of CCM1 Stroke, February 1, 2006; 37(2): 518 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Zawistowski, L. Stalheim, M. T. Uhlik, A. N. Abell, B. B. Ancrile, G. L. Johnson, and D. A. Marchuk CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis Hum. Mol. Genet., September 1, 2005; 14(17): 2521 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-N. Fournier, S. Dupe-Manet, D. Bouvard, F. Luton, S. Degani, M. R. Block, S. F. Retta, and C. Albiges-Rizo Nuclear Translocation of Integrin Cytoplasmic Domain-associated Protein 1 Stimulates Cellular Proliferation Mol. Biol. Cell, April 1, 2005; 16(4): 1859 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Plummer, C. J. Gallione, S. Srinivasan, J. S. Zawistowski, D. N. Louis, and D. A. Marchuk Loss of p53 Sensitizes Mice with a Mutation in Ccm1 (KRIT1) to Development of Cerebral Vascular Malformations Am. J. Pathol., November 1, 2004; 165(5): 1509 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Verlaan, S. B. Laurent, U. Sure, H. Bertalanffy, E. Andermann, F. Andermann, G. A. Rouleau, and A. M. Siegel CCM1 mutation screen of sporadic cases with cerebral cavernous malformations Neurology, April 13, 2004; 62(7): 1213 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Whitehead, N. W. Plummer, J. A. Adams, D. A. Marchuk, and D. Y. Li Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations Development, March 15, 2004; 131(6): 1437 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jobard, B. Bouadjar, F. Caux, S. Hadj-Rabia, C. Has, F. Matsuda, J. Weissenbach, M. Lathrop, J.-F. Prud'homme, and J. Fischer Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome Hum. Mol. Genet., April 15, 2003; 12(8): 925 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Marchuk, S. Srinivasan, T. L. Squire, and J. S. Zawistowski Vascular morphogenesis: tales of two syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R97 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gunel, M. S. H. Laurans, D. Shin, M. L. DiLuna, J. Voorhees, K. Choate, C. Nelson-Williams, and R. P. Lifton KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein PNAS, August 6, 2002; 99(16): 10677 - 10682. [Abstract] [Full Text] [PDF] |
||||











